LHYFE financials
LHYFE
969500RTYSRSTZAJCG72 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €5.1M | €1.3M |
| Employee benefits expense | €16.9M | €20.6M |
| Raw materials & consumables used | €891.0K | €645.0K |
| Depreciation & amortisation | €3.5M | €3.3M |
| Operating profit (EBIT) | -€29.0M | -€34.4M |
| Net finance income / (cost) | €1.2M | €1.6M |
| Profit before tax | -€27.8M | -€32.8M |
| Income tax expense | €0 | €0 |
| Profit for the year | -€29.2M | -€33.6M |
| — attributable to owners | -€29.1M | -€33.5M |
| — attributable to NCI | -€94.0K | -€69.0K |
| Total comprehensive income | -€29.2M | -€33.6M |
| Per share | ||
| Basic EPS | €-0.61 | €-0.70 |
| Free cash flow / share | €-1.13 | €-1.18 |
| Cash flow statement | ||
| Net cash from operating activities | -€27.0M | -€22.6M |
| Net cash from investing activities | -€34.6M | -€44.1M |
| Purchase of PP&E (capex) | €27.1M | €34.1M |
| Purchase of intangibles | €8.0M | €6.3M |
| Net cash from financing activities | €19.5M | €36.5M |
| Repayments of borrowings | €2.3M | €1.1M |
| Lease liability payments | €2.0M | €910.0K |
| Balance sheet | ||
| Total assets | €222.5M | €200.5M |
| Non-current assets | €126.6M | €74.7M |
| Property, plant & equipment | €74.6M | €50.3M |
| Right-of-use assets | €30.5M | €7.8M |
| Intangible assets & goodwill | €18.3M | €11.0M |
| Current assets | €95.8M | €125.8M |
| Trade & other receivables | €2.0M | €604.0K |
| Cash & equivalents | €72.1M | €114.3M |
| Total equity | €71.7M | €102.4M |
| — attributable to owners | €71.8M | €102.5M |
| Non-controlling interests | -€163.0K | -€69.0K |
| Non-current liabilities | €99.4M | €68.8M |
| Current liabilities | €51.4M | €29.3M |
| Trade & other payables | €21.2M | €15.2M |
| Deferred tax liabilities | €0 | €0 |
| Derived metrics | ||
| Free cash flow | -€54.1M | -€56.7M |
| Operating margin | -568.8% | -2609.6% |
| Net margin | -572.4% | -2548.0% |
| Return on equity | -40.7% | -32.8% |
| Cash conversion ratio | 0.92× | 0.67× |
| Capex coverage | -1.00× | -0.66× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€71.0K | -€34.0K |
| Adjustments For Decrease Increase In Other Operating Receivables | -€8.3M | -€6.0M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€1.4M | -€541.0K |
| Adjustments For Fair Value Gains Losses | €846.0K | €76.0K |
| Adjustments For Finance Income Cost | -€1.1M | -€596.0K |
| Adjustments For Increase Decrease In Other Operating Payables | €5.2M | €5.8M |
| Adjustments For Increase Decrease In Trade Account Payable | €693.0K | €4.2M |
| Adjustments For Sharebased Payments | -€1.4M | €2.6M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -€1.4M | -€803.0K |
| Cash and Cash Equivalents In Subsidiary Or Businesses Acquired Or Disposed2013 | €0 | -€2.1M |
| Current Derivative Financial Assets | €430.0K | €0 |
| Current Derivative Financial Liabilities | €402.0K | €0 |
| Current Provisions | €20.0K | €44.0K |
| Deferred Tax Assets | €0 | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€9.0K | €1.0K |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | €0 | €0 |
| Increase Decrease In Cash and Cash Equivalents | -€42.1M | -€30.2M |
| Increase Decrease Through Sharebased Payment Transactions | €1.4M | €2.6M |
| Increase Decrease Through Treasury Share Transactions | -€163.0K | -€113.0K |
| Interest Paid Classified As Financing Activities | €4.6M | €2.0M |
| Inventories Total | €248.0K | €176.0K |
| Investments In Joint Ventures Accounted For Using Equity Method | €965.0K | €2.4M |
| Issue of Equity | €27.0K | €3.0K |
| Issued Capital | €480.0K | €479.0K |
| Liabilities | €222.5M | €200.5M |
| Noncurrent Derivative Financial Assets | €0 | €0 |
| Noncurrent Derivative Financial Liabilities | €599.0K | €0 |
| Noncurrent Government Grants | €24.2M | €16.3M |
| Noncurrent Provisions | €3.5M | €3.2M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €0 | €0 |
| Other Comprehensive Income Net of Tax Exchange Differences On Translation | -€48.0K | -€56.0K |
| Other Comprehensive Income Net of Tax Financial Assets Measured At Fair Value Through Other Comprehensive Income | €0 | €0 |
| Other Comprehensive Income Net of Tax Gains Losses On Hedging Instruments That Hedge Investments In Equity Instruments | €0 | €0 |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | -€48.0K | -€56.0K |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Before Tax | €0 | €0 |
| Other Finance Income Cost | €2.6M | €2.3M |
| Other Noncurrent Assets | €2.3M | €3.2M |
| Payments To Acquire Or Redeem Entitys Shares | €164.0K | €113.0K |
| Proceeds From Government Grants Classified As Financing Activities | €12.2M | €7.9M |
| Proceeds From Issuing Shares | €27.0K | €3.0K |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | €5.0K | €1.0K |
| Retained Earnings Profit Loss For Reporting Period | -€29.1M | -€33.5M |
| Revenue From Contracts With Customers | €5.1M | €1.3M |
| Services Expense | €12.5M | €12.4M |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -€1.4M | -€803.0K |
| Share Premium | €163.8M | €163.8M |
| Tax Expense Other Than Income Tax Expense | €230.0K | €172.0K |
Every line item above is a fact tagged in LHYFE's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.